There are over 300,000 marketed over-the-counter (OTC) drug products on the market today, according to the US Food and Drug Administration (FDA). As some pharmaceuticals transition from prescription to over-the-counter status, this figure continues to rise year after year.
OTC pharmaceuticals, often known as non-prescription drugs, are medications that can be purchased without a prescription at a drugstore in Lodi, New Jersey. When you follow the label's and your doctor's directions, they are both effective and safe. Common health concerns treated with OTC drugs include the flu, colds, minor aches and pains, constipation, and fever. Tablets, liquids, sprays, and ointments are among the various types available.
The Indian OTC Drugs Market is segmented by product (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals, and Supplements (VMS), and Other Products), as well as distribution channel (Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels). The value (in USD million) of the above segments is provided in the report.
Over the next five years, the Indian over-the-counter pharmaceuticals (OTC) market is expected to increase at a CAGR of 9.2%.
The pandemic of COVID-19 is predicted to have a major influence on the market. India's manufacturers, for example, rely significantly on API supplies from China. Because of the lockdown, API manufacturing has slowed, leading in lower availability and increased costs for the resources needed to make the products. The government has imposed export restrictions on some vital medicines due to rising demand for OTC drugs. Aside from paracetamol, an over-the-counter pain reliever and fever reducer, medications barred for export include metronidazole, a common antibiotic, and pharmaceuticals used to treat malaria.
Being from a city and having a chronic ailment were linked in a cross-sectional study to the chance of ingesting drugs without a prescription. Self-medication, on the other hand, was considered as being influenced by factors such as wealth, occupation, and education. In November 2019, the overall mean prevalence of self-medication (SM) practises in India was 53.57 percent, according to an article published in Current Clinical Pharmacology. Self-medication appears to be influenced by familiarity with the medication, with a prevalence rate of 26.31 percent among those from a middle-lower socioeconomic background. Furthermore, mild symptoms, such as headaches, were the leading cause of SM.
Non-prescription medications are referred to as over-the-counter drugs in the scope of the report. Individuals can get these medications without a doctor's prescription and they are safe to consume without it. OTC medications have a wide range of therapeutic purposes, from weight loss to analgesics.
The Indian OTC Drugs Market is segmented by product (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals, and Supplements (VMS), and Other Products), as well as distribution channel (Hospital Pharmacies, Retail Pharmacies and Other Distribution Channels). The value (in USD million) of the above segments is provided in the report.
Headaches, fevers, toothaches, musculoskeletal injuries and illnesses, and menstruation cramps are all popular uses for over-the-counter analgesics. The use of analgesics for self-medication is mostly motivated by pain. According to a paper published in the Indian Journal of Palliative Care in October 2018, a population study of Indian people indicated a greater prevalence of chronic pain (CP) when compared to previous Asian pain prevalence studies. Acetaminophen and nonsteroidal anti-inflammatory medicines (NSAIDs) such as aspirin, naproxen, and ibuprofen are the most often used OTC analgesics in India. The rise in self-medication with over-the-counter analgesics and the introduction.
Comments
Post a Comment